Australian Clinical Labs Limited (ASX:ACL)

share price: (EoD)

earnings per share:

dividends per share:

Australian Clinical Labs Limited (ASX:ACL) is an Australian private provider of pathology services. The company has 86 accredited laboratories performing a diverse range of pathology tests each year for a range of clients including doctors, specialists, patients, hospitals and corporate clients. ACL is one of the largest private hospital pathology businesses nationally.

Australian Clinical Labs Limited (ASX:ACL) share price

Australian Clinical Labs Limited (ASX:ACL) passive income

Today's ASX news

How you could value the NAB share price using dividend yield

NAB share price is fast approaching $34: you can use these approaches to study NAB shares

Resmed CDI stock and Woolworths Group Ltd (ASX:WOW) shares are 2 ASX shares to watch

Is the ANZ Banking Group share price be good value?

CBA share price valuation: some easy ways to research it

Australian Clinical Labs Limited (ASX:ACL) share price news

ASX Growth Shares

Australian Clinical Labs (ASX:ACL) upgrades guidance as Omicron testing surges

The Australian Clinical Labs Ltd (ASX: ACL) share price is up more than 5% after the company upgraded first-half guidance expectations.

December 21, 2021

Rask Media

Rask Australia

Important Info

Invest with owen:

General Financial Advice warning

The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.